Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis

Rasheed A Balogun¹, Amber P Sanchez², Reinhard Klingel^{3

4}, Volker Witt⁵, Nicole Aqui⁶, Erin Meyer⁷, Anand Padmanabhan⁸, Huy P Pham⁹, Jennifer Schneiderman¹⁰, Joseph Schwartz¹¹, Yanyun Wu¹², Nicole D Zantek¹³, Laura Connelly-Smith¹⁴, Nancy M Dunbar¹⁵

Affiliations

¹ Division of Nephrology, University of Virginia, Charlottesville, Virginia, USA.
² Department of Medicine, Division of Nephrology, University of California, and Therapeutic Apheresis Program, UCSD Medical Center, San Diego, California, USA.
³ Apheresis Research Institute, Cologne, Germany.
⁴ First Department of Internal Medicine, University of Mainz, Mainz, Germany.
⁵ Department for Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁷ American Red Cross, Columbus, Ohio, USA.
⁸ Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁹ Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
¹⁰ Department of Pediatric Hematology/Oncology/Neuro-oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
¹¹ Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.
¹² Department of Pathology and Laboratory Medicine, University of Miami, Miami, Florida, USA.
¹³ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
¹⁴ Department of Medicine, Seattle Cancer Care Alliance & University of Washington, Seattle, Washington, USA.
¹⁵ Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

PMID: 32770558
DOI: 10.1002/jca.21820

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis

Rasheed A Balogun et al. J Clin Apher. 2020 Sep.

. 2020 Sep;35(5):493-499.

doi: 10.1002/jca.21820. Epub 2020 Aug 7.

Authors

Affiliations

¹ Division of Nephrology, University of Virginia, Charlottesville, Virginia, USA.
² Department of Medicine, Division of Nephrology, University of California, and Therapeutic Apheresis Program, UCSD Medical Center, San Diego, California, USA.
³ Apheresis Research Institute, Cologne, Germany.
⁴ First Department of Internal Medicine, University of Mainz, Mainz, Germany.
⁵ Department for Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁷ American Red Cross, Columbus, Ohio, USA.
⁸ Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁹ Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
¹⁰ Department of Pediatric Hematology/Oncology/Neuro-oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
¹¹ Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.
¹² Department of Pathology and Laboratory Medicine, University of Miami, Miami, Florida, USA.
¹³ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
¹⁴ Department of Medicine, Seattle Cancer Care Alliance & University of Washington, Seattle, Washington, USA.
¹⁵ Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

PMID: 32770558
DOI: 10.1002/jca.21820

Abstract

Since 1986, the American Society for Apheresis (ASFA) has published practice guidelines on the use of therapeutic apheresis in the Journal of Clinical Apheresis (JCA) Special Issue. Since 2007, updated guidelines have been published every 3 years to reflect current evidence based apheresis practice with the most recent edition (8th) published in 2019. With each edition, the guidelines are reviewed and updated based on any newly published literature since the last review. The PEXIVAS study, an international, randomized controlled trial comparing therapeutic plasma exchange (TPE) vs no TPE and standard vs reduced dose steroid regimen on the primary composite outcome of end stage renal disease or death in patients with ANCA-associated vasculitis (AAV), was published in February 2020. This study represents the largest study on the role of therapeutic apheresis in AAV published to date and prompted the JCA Special Issue Writing Committee to reassess the current AAV fact sheet for updates based on this newly available evidence. This interim fact sheet summarizes current ASFA recommendations for the evidence-based use of therapeutic apheresis in AAV and supersedes the recommendations published in the 2019 guidelines.

Keywords: ANCA; therapeutic apheresis; vasculitis.

PubMed Disclaimer

References

REFERENCES

1. Walsh M, Merkel PA, Peh CA, et al. Plasma exchange and glucocorticoids in severe ANCA-associated Vasculitis. N Engl J Med. 2020;382(7):622-631.
1. Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: the sixth special issue. J Clin Apher. 2013;28:145-284.
1. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the seventh special issue. J Clin Apher. 2016;31:149-162.
1. Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171-354.
1. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest. 2006;129:174-181.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis

Affiliations

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis

Authors

Affiliations

Abstract

References

REFERENCES

MeSH terms

LinkOut - more resources

Full Text Sources